The Journal of Oncology and Cancer Research (JOCR) publishes high-quality original research articles, reviews, short communications, case studies, and clinical perspectives that address every aspect of cancer biology, oncology practice, and translational cancer research. We welcome submissions across a diverse range of thematic areas, including (but not limited to):

     Cancer Biology & Tumor Microenvironment

• Molecular mechanisms of carcinogenesis and tumor progression
• Tumor microenvironment, angiogenesis, metastasis, and immune evasion
• Cancer stem cells, cellular signaling pathways, and epigenetic regulation
• Genomics, proteomics, metabolomics, and biomarker discovery
  
   Medical, Surgical & Radiation Oncology
   
•  Advances in chemotherapy, radiotherapy, immunotherapy, and targeted therapy
• Precision oncology, pharmacogenomics, and personalized medicine
• Minimally invasive cancer surgeries and interventional oncology
•  Treatment toxicity management and supportive oncology care

         Hematologic Malignancies

• · Leukemia, lymphoma, myeloma, and myeloproliferative neoplasms
• · Bone marrow transplantation, cell therapy, and graft-versus-host disease
• · Hematologic cancer diagnostics, imaging, and molecular classification
• · Advances in CAR-T therapy and immuno-oncology approaches

            Solid Tumors & Organ-Specific Cancers

• Breast, lung, colorectal, prostate, and gynecologic cancers
• Head and neck cancers, brain tumors, gastrointestinal malignancies
• Sarcomas, melanoma, pediatric cancers, and rare tumors Tumor staging, imaging, surgical strategies, and integrated management

      Cancer Immunology & Immunotherapy

•  Immune checkpoint inhibitors, vaccines, monoclonal antibodies
• Tumor-infiltrating lymphocytes, cytokine therapy, and NK-cell research
•  Immune microenvironment profiling and immune-escape mechanisms
•  Emerging immunotherapeutic technologies and clinical applications

      Cancer Prevention, Screening & Early Detection

• Population-based cancer screening programs and diagnostic innovations
•  Lifestyle, environmental, and genetic risk factors
• Early detection biomarkers, liquid biopsy, and advanced imaging
•  Public health strategies and preventive oncology

      Translational & Experimental Oncology

• Preclinical drug discovery, nanomedicine, and experimental therapeutics
• Organoids, 3D models, xenografts, and animal models of cancer Mechanistic studies, pathway targeting, and drug resistance research
• Translational approaches bridging laboratory findings to clinical practice

       Psycho-Oncology, Survivorship & Palliative Care

• Quality of life, symptom management, and long-term survivorship
•  Psychosocial oncology, mental health, and caregiver support
• Pain management, end-of-life care, and palliative interventions
• Rehabilitation, nutrition, and holistic cancer care

         Oncology Technology, AI & Innovations

• AI/ML in cancer diagnosis, prognosis, and treatment planning
• Radiomics, digital pathology, and computational oncology
•  Wearables, remote monitoring, and tele-oncology applications
• Innovative medical technologies and future cancer care advancements